BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

  March 5, 2025

   · 

  6 min read
• Press Releases

  PharmaEssentia Highlights Availability of BESREMi® (ropeginterferon alfa-2b-njft) for Patients Affected by Pegasys® (peginterferon alfa-2a) Drug Shortage

  March 5, 2025

   · 

  4 min read
• Press Releases

  Accuryn Medical Achieves Sales Milestone of 100,000 Catheters Shipped Nationwide

  March 5, 2025

   · 

  2 min read
• Press Releases

  Enspire DBS Therapy Announces the First Patient Implanted in the Second Center for RESTORE, a Multicenter Pivotal Phase 2/3 Clinical Trial for the Treatment of Arm Weakness and Reduced Function after Stroke

  March 5, 2025

   · 

  5 min read
• Press Releases

  NanoNewron Appoints Industry Veteran Marco Taglietti, M.D., as Chief Executive Officer to Lead the Company and the Development of Their Promising Alzheimer’s Compound

  March 5, 2025

   · 

  5 min read
• Press Releases

  IO Biotech Reports 2024 Business Highlights

  March 5, 2025

   · 

  11 min read
• Press Releases

  Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025

  March 5, 2025

   · 

  1 min read
• Press Releases

  Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights

  March 5, 2025

   · 

  10 min read
• Press Releases

  Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy

  March 5, 2025

   · 

  7 min read
• Press Releases

  The US FDA Grants Both Orphan Drug and Rare Pediatric Disease Designations to NEU-001 of Neurenati for the Treatment of Hirschsprung Disease

  March 5, 2025

   · 

  3 min read